SOLARA ACTIVE PHARMA SCIENCES
Back to Balance Sheet
|
SOLARA ACTIVE PHARMA SCIENCES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹183 Cr | ₹191 Cr | ₹172 Cr | ₹217 Cr | ₹299 Cr |
What is the latest Total Non-Current Liabilities ratio of SOLARA ACTIVE PHARMA SCIENCES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹183 Cr |
| Mar2025 | ₹191 Cr |
| Mar2024 | ₹172 Cr |
| Mar2023 | ₹217 Cr |
| Mar2022 | ₹299 Cr |
How is Total Non-Current Liabilities of SOLARA ACTIVE PHARMA SCIENCES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹183 Cr | -4.03 | |
| Mar2025 | ₹191 Cr | 11.25 | |
| Mar2024 | ₹172 Cr | -21.00 | |
| Mar2023 | ₹217 Cr | -27.43 | |
| Mar2022 | ₹299 Cr | - | |
Compare Total Non-Current Liabilities of peers of SOLARA ACTIVE PHARMA SCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SOLARA ACTIVE PHARMA SCIENCES | ₹3,116.8 Cr | -4.6% | -8.2% | 6.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,539.0 Cr | -1.4% | -6.6% | 7.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,576.0 Cr | 1.2% | -2.6% | 60% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,251.0 Cr | -2% | -6.1% | 33% | Stock Analytics | |
| CIPLA | ₹105,290.0 Cr | -2.3% | -5.8% | -13.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,752.6 Cr | -1.1% | 3.8% | -5.5% | Stock Analytics | |
SOLARA ACTIVE PHARMA SCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SOLARA ACTIVE PHARMA SCIENCES | -4.6% |
-8.2% |
6.2% |
| SENSEX | 0.8% |
-4.8% |
-10.5% |
You may also like the below Video Courses